Cargando…

Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3

We previously found that, among human parainfluenza virus type 3 (HPIV3) proteins, the interaction of nucleoprotein (N) and phosphoprotein (P) provides the minimal requirement for the formation of cytoplasmic inclusion bodies (IBs), which are sites of RNA synthesis, and that acetylated α-tubulin enh...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Pengfei, Zhang, Shengwei, Ma, Jingyi, Jin, Dongning, Qin, Yali, Chen, Mingzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524669/
https://www.ncbi.nlm.nih.gov/pubmed/36108090
http://dx.doi.org/10.1371/journal.ppat.1010856
_version_ 1784800544423936000
author Liu, Pengfei
Zhang, Shengwei
Ma, Jingyi
Jin, Dongning
Qin, Yali
Chen, Mingzhou
author_facet Liu, Pengfei
Zhang, Shengwei
Ma, Jingyi
Jin, Dongning
Qin, Yali
Chen, Mingzhou
author_sort Liu, Pengfei
collection PubMed
description We previously found that, among human parainfluenza virus type 3 (HPIV3) proteins, the interaction of nucleoprotein (N) and phosphoprotein (P) provides the minimal requirement for the formation of cytoplasmic inclusion bodies (IBs), which are sites of RNA synthesis, and that acetylated α-tubulin enhances IB fusion and viral replication. In this study, using immunoprecipitation and mass spectrometry assays, we determined that vimentin (VIM) specifically interacted with the N–P complex of HPIV3, and that the head domain of VIM was responsible for this interaction, contributing to the inhibition of IB fusion and viral replication. Furthermore, we found that VIM promoted the degradation of α-tubulin acetyltransferase 1 (α-TAT1), through its head region, thereby inhibiting the acetylation of α-tubulin, IB fusion, and viral replication. In addition, we identified a 20-amino-acid peptide derived from the head region of VIM that participated in the interaction with the N–P complex and inhibited viral replication. Our findings suggest that VIM inhibits the formation of HPIV3 IBs by downregulating α-tubulin acetylation via enhancing the degradation of α-TAT1. Our work sheds light on a new mechanism by which VIM suppresses HPIV3 replication.
format Online
Article
Text
id pubmed-9524669
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-95246692022-10-01 Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3 Liu, Pengfei Zhang, Shengwei Ma, Jingyi Jin, Dongning Qin, Yali Chen, Mingzhou PLoS Pathog Research Article We previously found that, among human parainfluenza virus type 3 (HPIV3) proteins, the interaction of nucleoprotein (N) and phosphoprotein (P) provides the minimal requirement for the formation of cytoplasmic inclusion bodies (IBs), which are sites of RNA synthesis, and that acetylated α-tubulin enhances IB fusion and viral replication. In this study, using immunoprecipitation and mass spectrometry assays, we determined that vimentin (VIM) specifically interacted with the N–P complex of HPIV3, and that the head domain of VIM was responsible for this interaction, contributing to the inhibition of IB fusion and viral replication. Furthermore, we found that VIM promoted the degradation of α-tubulin acetyltransferase 1 (α-TAT1), through its head region, thereby inhibiting the acetylation of α-tubulin, IB fusion, and viral replication. In addition, we identified a 20-amino-acid peptide derived from the head region of VIM that participated in the interaction with the N–P complex and inhibited viral replication. Our findings suggest that VIM inhibits the formation of HPIV3 IBs by downregulating α-tubulin acetylation via enhancing the degradation of α-TAT1. Our work sheds light on a new mechanism by which VIM suppresses HPIV3 replication. Public Library of Science 2022-09-15 /pmc/articles/PMC9524669/ /pubmed/36108090 http://dx.doi.org/10.1371/journal.ppat.1010856 Text en © 2022 Liu et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Liu, Pengfei
Zhang, Shengwei
Ma, Jingyi
Jin, Dongning
Qin, Yali
Chen, Mingzhou
Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3
title Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3
title_full Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3
title_fullStr Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3
title_full_unstemmed Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3
title_short Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3
title_sort vimentin inhibits α-tubulin acetylation via enhancing α-tat1 degradation to suppress the replication of human parainfluenza virus type 3
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524669/
https://www.ncbi.nlm.nih.gov/pubmed/36108090
http://dx.doi.org/10.1371/journal.ppat.1010856
work_keys_str_mv AT liupengfei vimentininhibitsatubulinacetylationviaenhancingatat1degradationtosuppressthereplicationofhumanparainfluenzavirustype3
AT zhangshengwei vimentininhibitsatubulinacetylationviaenhancingatat1degradationtosuppressthereplicationofhumanparainfluenzavirustype3
AT majingyi vimentininhibitsatubulinacetylationviaenhancingatat1degradationtosuppressthereplicationofhumanparainfluenzavirustype3
AT jindongning vimentininhibitsatubulinacetylationviaenhancingatat1degradationtosuppressthereplicationofhumanparainfluenzavirustype3
AT qinyali vimentininhibitsatubulinacetylationviaenhancingatat1degradationtosuppressthereplicationofhumanparainfluenzavirustype3
AT chenmingzhou vimentininhibitsatubulinacetylationviaenhancingatat1degradationtosuppressthereplicationofhumanparainfluenzavirustype3